• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    (NY: BLCO )

    14.52 -0.25 (-1.69%)
    Official Closing Price Updated: 7:00 PM EDT, Jun 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 669,515
    Open 14.75
    Bid (Size) 14.29 (1)
    Ask (Size) 15.30 (1)
    Prev. Close 14.77
    Today's Range 14.41 - 14.91
    52wk Range 13.16 - 21.95
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Is Clearside Biomedical Stock Gaining Today?
    Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS... 
    Via Benzinga
    Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
    From Bausch + Lomb Corporation
    Via Business Wire

    Performance

    YTD
    -14.18%
    -14.18%
    1 Month
    -5.65%
    -5.65%
    3 Month
    -14.89%
    -14.89%
    6 Month
    -14.18%
    -14.18%
    1 Year
    -27.65%
    -27.65%

    More News

    Read More
    Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
    From Bausch + Lomb Corporation
    Via Business Wire
    Barclays Maintains Equal-Weight Rating for Bausch & Lomb: Here's What You Need To Know
    Via Benzinga
    Do You Have Your Eye On Vision Care Stocks?
    Via Talk Markets
    American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    BLCO Stock Earnings: Bausch & Lomb Meets EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Bausch + Lomb Announces First-Quarter 2024 Results
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
    From Bausch + Lomb Corporation
    Via Business Wire
    Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors
    From Bausch + Lomb Corporation
    Via Business Wire
    Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Eye Care-Focused Bausch + Lomb's Stock Surges On Upbeat Annual Guidance Despite Deeper Losses
    Via Benzinga
    Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
    From Emergent BioSolutions
    Via GlobeNewswire
    Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance
    From Bausch + Lomb Corporation
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.